Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Takeda
 More »

  • Layoffs Imminent at Astellas: Two U.S. Labs to Close
    ... Astellas follows other pharma giants that have shrunk their R&D operations in recent years-a category that includes AstraZeneca, Roche, Pfizer, and Takeda-as companies scramble to ...
    5-14-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Financial terms not disclosed. Roche (Ventana Medical Systems) and Seattle Genetics and Takeda Pharmaceutical (Millennium: The Takeda Oncology Company) Agreement announced April ...
    5-9-2013
  • Booster Shot: Takeda Buys Inviragen
    Takeda Pharmaceutical acquired Inviragen in an up-to-$250 million deal designed to bolster ... Takeda will pay $35 million up-front, and the remaining $215 million in potential payments ...
    5-8-2013
  • Harnessing the Power of Kinase Inhibitors
    ... unique binding mode was shared with another series published by Takeda Pharmaceutical. ... Other cyclical chemical templates from AstraZeneca, Abbott Laboratories, and Takeda ...
    5-8-2013
  • GEN | Biolinks
    ... Metabolomic Discoveries Gmbh MichBio Michigan Economic Development Corporation Michigan State University Millennium: The Takeda Oncology Company Ministry of Education, Culture, ...
  • Enzon Gives Up Hope to Sell
    On February 23, Omontys marketer Affymax and its development and commercialization partner Takeda Pharmaceutical voluntarily recalled all lots of the drug. That action followed at ...
    4-24-2013
  • Chicago Plans Biotech Commercialization Center
    Laboratories and its new prescription-drug spinoff AbbVie; or have U.S. headquarters in the region, such as Japanese drug developers Astellas Pharma and Takeda Pharmaceutical. ...
    4-24-2013
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    ... value of mergers and acquisitions involving U.S. or European biotechs rose last year to $27.4 billion, up 9% over 2011 excluding the Sanofi-Genzyme and Takeda-Nycomed megamergers. ...
    4-22-2013
  • Five Japanese Pharmas Join Drug-Development Fund
    Astellas Pharma, Daiichi Sankyo, Eisai, Shionogi, and Takeda Pharmaceutical have joined ... Takeda said in its statement that its participation in GHIT is part of a broader ...
    4-8-2013
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    1 Marketer(s): Pfizer and Takeda Indication(s): Moderately to severely active rheumatoid arthritis in adults who have had an inadequate response or intolerance to methotrexate. ...
    4-4-2013
  • Scaling Up Peptide Drugs
    Labs), a pulmonary surfactant for intratracheal use; Omontys® (peginesatide, Affymax/Takeda) to treat anemia due to chronic kidney disease in adults on dialysis; Kyprolis(tm) ...
    4-1-2013
  • NPS Buys Teduglutide, PTH 1-84 Rights from Takeda for Up to ...
    NPS Pharmaceuticals has acquired from Takeda Pharmaceutical full worldwide rights to ... in April 2006. In return for the rights, Takeda will receive from NPS $50 million in ...
    3-19-2013
  • Top 10 Biopharma Layoffs of 2012
    Announced: February 2, 2012; occurring over two years Projected savings: $1.6 billion annually by the end of 2014 Costs & charges: $2.1 billion 2. Takeda Total workforce reduction: ...
    3-15-2013
  • Takeda Expands Envoy-Scripps Collaboration
    The Scripps Research Institute (TSRI) and the Takeda Pharmaceutical Company are expanding ... Envoy was acquired by Takeda Pharmaceuticals last November to obtain access to Envoy's CNS ...
    3-13-2013
  • Presage, Celgene Put Heads Together to Find New Cancer Drug Combos
    Celgene isn't the only company that's picked Presage's brain on cancer drug combos: Millennium: The Takeda Oncology Company made a deal with Presage to find drug combinations that ...
    3-5-2013

  • Journal Articles

  • Ambulatory Tonometric Blood Pressure Measurements in Patients...
    Simone Theilade, Christel Joergensen, Frederik Persson, Maria Lajer, Peter Rossing
    Diabetes Technology & Therapeutics
    Methods We compare tonometric (BPro) to cuff-based oscillometric and auscultatory BPs (Takeda TM2421) in 25 Caucasian patients with type 1 or type 2 diabetes. Patients were seen ...
  • Competact, a Fixed Combination of Pioglitazone and Metformin...
    Andreas Pfützner, Thomas Schöndorf, Efstrathios Karagiannis, Richard E.K. Posseldt, Thomas Forst
    Diabetes Technology & Therapeutics
    Antidiabetes therapy has to be adapted according to the individual course of the disease. This trial investigates the impact of Competact(tm) (Takeda Pharma, Aachen, Germany) ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll